37
9
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T14348 |
Auristatin E
|
Microtubule Associated | Cytoskeletal Signaling |
Auristatin E 通过阻断微管蛋白的聚合来抑制细胞分裂。它是一种细胞毒性微管蛋白修饰剂,具有强效和选择性抗肿瘤活性。它是一种 MMAE 类似物,是抗体-药物偶联物中的细胞毒素。 | |||
T38889 |
Thailanstatin A
|
||
Thailanstatin A 是真核 RNA 剪接抑制剂,IC50为650 nM,通过非共价结合到剪接体的 U2 snRNA 亚复合物的 SF3b 亚单位发挥作用。Thailanstatin A 对多种癌细胞系的抑制显示 nM 级别的 IC50。它与 Trastuzumab 上的赖氨酸结合,可产生“无连接子” ADC。 | |||
T11249L |
Dxd
Exatecan derivative for ADC,OQM5SD32BQ,UNII-OQM5SD32BQ |
Topoisomerase | DNA Damage/DNA Repair |
Dxd (OQM5SD32BQ) 是一种有效的DNA 拓扑异构酶 I 抑制剂,IC50值为 0.31 μM,用作HER2靶向ADC 的偶联药物。 | |||
T14349 | Auristatin F | Microtubule Associated | Cytoskeletal Signaling |
Auristatin F 是一种有效的微管抑制剂和血管损伤剂。 Auristatin F 可用于抗体-药物偶联物。 | |||
T15141 |
DM4
Ravtansine,美登素 DM4 |
Others; Microtubule Associated | Cytoskeletal Signaling; Others |
DM4 (Ravtansine)可用于制备抗体药物偶联物,是抗微管蛋白剂。 它抑制细胞分裂。 | |||
T11120 |
Duocarmycin TM
|
DNA Alkylation; Antibiotic | DNA Damage/DNA Repair; Microbiology/Virology |
Duocarmycin TM 是一种有抗肿瘤活性的抗生素,也是一种 DNA 烷化剂。 | |||
T3256 |
MMAF
一甲基澳瑞他汀 F,MonoMethyl auristatin F |
Others; Microtubule Associated | Cytoskeletal Signaling; Others |
MMAF (MonoMethyl auristatin F) 是一种抗有丝分裂剂,通过阻断微管蛋白的聚合来抑制细胞分裂,用作抗肿瘤药物和抗体偶联药物的细胞毒性成分。 | |||
T12081 |
MMAF-OMe
Monomethyl auristatin F methyl ester |
||
MMAF-OMe (Monomethyl auristatin F methyl ester) 是一种抗微管蛋白剂,能够抑制 MDAMB435/5T4,MDAMB361DYT2,MDAMB468 和 Raji (5T4-) 这四种肿瘤细胞,IC50值分别为 0.056 nM,0.166 nM,0.183 nM 和 0.449 nM。它也是ADC 细胞毒素。 | |||
T8003 |
Methotrexate disodium
|
Apoptosis; Dehydrogenase; DNA/RNA Synthesis; Antifolate | Apoptosis; Cell Cycle/Checkpoint; DNA Damage/DNA Repair; Metabolism |
Methotrexate disodium 是一种叶酸类似物代谢抑制剂,具有免疫抑制剂和抗肿瘤特性,用于类风湿关节炎和研究多种癌症。 | |||
T16557 |
PNU-159682
|
Topoisomerase | DNA Damage/DNA Repair |
PNU-159682 是蒽环类新霉素的代谢产物,是一种 DNA 拓扑异构酶 II 抑制剂,具有出色的细胞毒性。 | |||
T1992 |
Mertansine
DM1,Maytansinoid DM1 |
Microtubule Associated | Cytoskeletal Signaling |
Mertansine (DM1) 是一种微管蛋白抑制剂,也是一种抗体可缀合的美登木素生物碱。它通过连接体连接到单克隆抗体上,形成抗体偶联药物。 | |||
T14858 |
Calicheamicin
Calicheamicin γ1,卡奇霉素 |
Others | Others |
Calicheamicin (Calicheamicin γ1) 是肿瘤抗生素,可引起DNA 双链断裂,抑制DNA 合成。 | |||
T21408 |
DM1-SMe
DM1-SSMe |
Microtubule Associated | Cytoskeletal Signaling |
DM1-SMe (DM1-SSMe) 是美登木素微管的有效抑制剂。 DM1-SMe 的效力是母体药物美登素的 3 至 10 倍,在一组人类肿瘤细胞系中,DM1-SMe 的 IC50 为 0.003 至 0.01 nM。 | |||
T6897 |
Monomethyl auristatin E
一甲基澳瑞他汀E,Vedotin,MMAE |
Apoptosis; Microtubule Associated | Apoptosis; Cytoskeletal Signaling |
Monomethyl auristatin E (MMAE) 是海兔毒素 10 的合成衍生物,是一种抗有丝分裂剂,通过阻断微管蛋白的聚合来抑制细胞分裂,并且还具有抑制抗体-药物偶联物的活性。 | |||
T1910 |
Ansamitocin P 3'
Maytansinol butyrate,Ansamitocin P-3,安丝菌素P-3,Antibiotic C 15003P3' |
Microtubule Associated | Cytoskeletal Signaling |
Ansamitocin P 3' (Maytansinol butyrate) 是一种具有抗肿瘤活性的抗体-药物偶联细胞毒素。 | |||
T4677 |
MMAD
Monomethylauristatin D,Demethyldolastatin 10,单甲基澳瑞他汀 D,Monomethyl Dolastatin 10 |
Microtubule Associated | Cytoskeletal Signaling |
MMAD (Demethyldolastatin 10) 是一种有效的微管蛋白抑制剂,是抗体药物偶联物中的一种毒素有效载荷。 | |||
T11917 |
Lys-SMCC-DM1
Lys-Nε-MCC-DM1 |
Microtubule Associated | Cytoskeletal Signaling |
DM1 是一种微管蛋白抑制剂。 Lys-SMCC-DM1 (Lys-Nε-MCC-DM1) 是 DM1 的活性代谢物。 | |||
T1485 |
Methotrexate
NCI-C04671,WR19039,Amethopterin,甲氨蝶呤,CL14377 |
Apoptosis; Dehydrogenase; DNA/RNA Synthesis; Antifolate | Apoptosis; Cell Cycle/Checkpoint; DNA Damage/DNA Repair; Metabolism |
Methotrexate (WR19039) 是一种叶酸类似物,一种二氢叶酸还原酶 DHFR 的抑制剂。Methotrexate 具有抗代谢、抗肿瘤和免疫抑制等活性,常用于类风湿关节炎和多种肿瘤的研究。 | |||
T12149 |
N-Me-L-Ala-maytansinol
|
Others | Others |
N-Me-L-Ala-maytansinol used for making antibody-drug conjugate (ADC),is a hydrophobic, cell permeable payload. | |||
T40049 |
MC-AAA-NHCH2OCH2COO-7-aminomethyl-10-methyl-11-fluoro camptothecin
MC-AAA-NHCH2OCH2COO-7-aminomethyl-10-methyl-11-fluoro camptothecin |
||
MC-AAA-NHCH2OCH2COO-7-aminomethyl-10-methyl-11-fluoro camptothecin (compound 21a), is a camptothecin payload which can be utilized in the synthesis of a camptothecin antibody-drug conjugate (ADC) by conjugation to a monoclonal antibody (mAb). | |||
T81144 | SMP-93566 | ||
SMP-93566为一抗体-药物偶联物(Antibody-Drug Conjugates (ADCs)),其有效载荷(payload)脱落率低,可在体内抑制卵巢癌、胃癌及乳腺癌肿瘤。 | |||
T18701 |
SPDB-DM4
|
Others | Others |
SPDB-DM4 is a drug-linker conjugate designed for antibody-drug conjugate (ADC) applications, employing the maytansine-based payload DM4 (a tubulin inhibitor) connected through a SPDB linker. This compound demonstrates significant anti-tumor efficacy. | |||
T81146 | SMP-33693 | ||
SMP-33693为一种抗体-药物偶联物(Antibody-Drug Conjugates (ADCs)),其有效载荷(payload)稳定性高,显示出对卵巢癌、胃癌及乳腺癌肿瘤的体内抑制作用。 | |||
T15872 |
m-PEG4-Br
|
Others | Others |
m-PEG4-Br is a cleavable ADC linker used in the synthesis of antibody-drug conjugate (ADC) for Trastuzumab. m-PEG4-Br is placed distally from the monomethyl auristatin E (MMAE) payload to yield an ADC with altered hydrophilicity, antigen binding, and in v | |||
T39458 |
DGN549-C
DGN549-C |
||
DGN549-C is a novel compound featuring a cleavable ADC (antibody-drug conjugate) linker composed of valine-alanine (va) and a PBD (pyrrolobenzodiazepine) dimer. This compound possesses a unique DNA-alkylating cytotoxic payload, DGN549, which is utilized in the development of ADCs. | |||
T18477 |
NAMPT inhibitor-linker 1
|
Others | Others |
NAMPT inhibitor-linker 1, a drug-linker conjugate for ADC, integrates an NAMPT inhibitor (as a payload) with a linker. In the formulation of ADC-3, it pairs with an anti-c-Kit monoclonal antibody, demonstrating strong efficacy against c-Kit expressing cell lines, specifically GIST-T1 and NCI-H526, where it exhibits IC50 values of <3 pM and 9 pM, respectively. | |||
T79206 |
MC-EVCit-PAB-MMAE
|
||
MC-EVCit-PAB-MMAE (Linker-Payload 11) 作为一种ADC (drug-linker conjugates) 的代表,由具有功能性的ADC linker (MC-EVCit-PAB) 以及作为有效药物负载的微管蛋白聚合抑制剂MMAE组成。 | |||
T77910 |
Patritumab deruxtecan
U3-1287,HER3-DXd |
||
Patritumab deruxtecan (HER3-DXd)为一抗体-药物偶联物(ADC),其结构为全人源IgG1单克隆抗体Patritumab通过含四肽的裂解性连接子与拓扑异构酶 I 抑制剂药效团相连。 | |||
T74940 | Anticancer agent 81 | Apoptosis | Apoptosis |
Anticanceragent 81(Compound 37b3)是用于诱导肿瘤细胞发生周期阻滞和凋亡(apoptosis)的化合物。当Anticanceragent 81作为有效载荷与Trastuzumab结合时,可生成抗体药物偶联物(ADC)T-PBA,此ADC保留了Trastuzumab的靶向特性和内化功能。 | |||
T78638 |
Clezutoclax
|
||
Clezutoclax为Bcl-XL抑制剂且作为活性载体,可应用于抗体药物偶联物(ADC)的合成。 | |||
T18478 |
NAMPT inhibitor-linker 2
|
Others | Others |
NAMPT inhibitor-linker 2, a drug-linker conjugate for antibody-drug conjugates (ADCs), comprises an NAMPT inhibitor payload and a linker. When combined with an anti-c-Kit monoclonal antibody to form ADC-4, it demonstrates potent efficacy against c-Kit expressing cell lines, including GIST-T1 and NCI-H526, with IC50 values of <7 pM and 40 pM, respectively. | |||
T75086 | Dazostinag | ||
Dazostinag (TAK-676 free base) 为干扰素基因刺激剂 (STING) 蛋白的激动剂,展现出抗肿瘤活性。它能作为有效载荷 (payload) 用于合成抗体偶联活性分子 (ADC) 的构建。 | |||
T74562 | Nampt-IN-10 trihydrochloride | ||
Nampt-IN-10 trihydrochloride (compound 4) 为磷酸核糖转移酶 (NAMPT) 抑制剂。在A2780与CORL23细胞中展现出活性,IC50值依次为5和19 nM。Nampt-IN-10 trihydrochloride 同时作为抗体偶联活性分子 (ADC) 的非限制性有效载荷。 | |||
T18522 |
PC Mal-NHS carbonate ester
|
Others | Others |
PC Mal-NHS carbonate ester is a cleavable linker specifically designed for the synthesis of antibody-drug conjugates (ADCs)[1]. This chemical compound plays a crucial role in facilitating the conjugation of drugs to antibodies, enabling targeted delivery and enhanced efficacy of therapeutic agents. Its unique carbonate ester structure allows for efficient cleavage in the targeted environment, ensuring the controlled release of the drug payload. Its application in ADC synthesis highlights its imp... | |||
T75134 | MC-GGFG-AM-(10Me-11F-Camptothecin) | ||
MC-GGFG-AM-(10Me-11F-Camptothecin) 是ZW251合成的Linker-Payload偶联物。ZW251是靶向人GPC3的抗体-活性分子偶联物(ADC),包括人源化IgG1抗体、喜树碱(camptothecin)类的扑异构酶1抑制剂ZD06519及连接子(马来酰亚胺锚定和甘酰甘酰苯丙酰甘氨酸(GGFG)-氨基甲基(AM)可切割连接体)。该药物对人和食蟹猴GPC3具高亲和力,在表达GPC3的HCC细胞系中快速内化并可对GPC3阴性癌细胞进行旁观者介导杀伤。 | |||
T38503 |
(2-pyridyldithio)-PEG1-hydrazine
(2-pyridyldithio)-PEG1-hydrazine |
||
(2-Pyridyldithio)-PEG1-hydrazine is a one-unit cleavable polyethylene glycol (PEG) linker specifically designed for the synthesis of antibody-drug conjugates (ADCs). This linker offers the advantage of controlled release of the drug payload from the ADC construct. It is utilized in the conjugation process between the antibody and the cytotoxic drug, enabling the targeted delivery of the drug to cancer cells. The (2-pyridyldithio) group of this linker provides stability during circulation in the ... | |||
T82021 |
Izeltabart
IMGC-936 |
||
Izeltabart(IMGC-936)是一款针对ADAM9的基于Maytansinoid的ADC,由与DM21-C位点特异性偶联的高亲和力人源化抗体构成,使Maytansinoid微管破坏载体通过稳定的三肽连接子进行传递,达到药物-抗体比约为2.0。Izeltabart在ADAM9阳性人类肿瘤细胞系上显示出明显的细胞毒性,并在动物异种移植肿瘤模型中展现出显著的抗肿瘤效果。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T0968 |
Paclitaxel
Taxol,紫杉醇,NSC 125973 |
Apoptosis; Microtubule Associated; Autophagy | Apoptosis; Autophagy; Cytoskeletal Signaling |
Paclitaxel (Taxol) 属于天然产物,是一种微管聚合物稳定剂。Paclitaxel 具有抗肿瘤活性;通过诱导有丝分裂停滞、细胞凋亡、细胞自噬等,导致细胞死亡。 | |||
T16016 |
Maytansinol
美登醇,Ansamitocin P-0 |
Apoptosis; Microtubule Associated | Apoptosis; Cytoskeletal Signaling |
Maytansinol (Ansamitocin P-0) 在体外抑制微管组装并导致微管分解。它与辐射联用,用于果蝇和人类癌细胞。 | |||
TP1180 |
Dolastatin 10
尾海兔素10,NSC 376128,DLS 10 |
Microtubule Associated | Cytoskeletal Signaling |
Dolastatin 10 (DLS 10) 是一种多肽,可以抑制微管蛋白聚合,显示除抗有丝分裂的活性。 | |||
T1123 |
Camptothecin
NSC-100880,Campathecin,喜树碱,(S)-(+)-Camptothecin,CPT |
Apoptosis; Influenza Virus; Topoisomerase; Antibiotic; Antifungal | Apoptosis; DNA Damage/DNA Repair; Microbiology/Virology |
Camptothecin (CPT) 属于生物碱类天然产物,是一种 DNA 拓扑异构酶 I (Topo I) 的抑制剂 (IC50=679 nM),具有特异性。Camptothecin 具有抗肿瘤活性,可以诱导细胞凋亡。 | |||
T1703 |
SN-38
7-乙基-10-羟基喜树碱,NK012,伊立替康杂质B,SN 38 |
DNA/RNA Synthesis; Topoisomerase; Autophagy | Autophagy; Cell Cycle/Checkpoint; DNA Damage/DNA Repair |
SN-38 (NK012) 是 DNA 拓扑异构酶 I (Topo I) 抑制剂 Irinotecan 的活性代谢产物,可以抑制 DNA 和 RNA 合成 (IC50=0.077/1.3 μM)。SN-38 具有抗肿瘤活性,可以诱导细胞自噬。 | |||
T1020 |
Doxorubicin hydrochloride
Adriamycin,Doxorubicin (Adriamycin) HCl,Hydroxydaunorubicin hydrochloride,盐酸多柔比星,盐酸阿霉素,NSC 123127 |
Apoptosis; Mitophagy; HBV; HIV Protease; Topoisomerase; Antibacterial; Antibiotic; AMPK; Autophagy | Apoptosis; Autophagy; Chromatin/Epigenetic; DNA Damage/DNA Repair; Microbiology/Virology; PI3K/Akt/mTOR signaling; Proteases/Proteasome |
Doxorubicin hydrochloride (Adriamycin) 属于蒽环类抗生素,是人类 DNA 拓扑异构酶 I/II 抑制剂 (IC50=0.8/2.67 μM)。Doxorubicin hydrochloride 具有细胞毒性和抗肿瘤活性。Doxorubicin hydrochloride 可降低 AMPK 及其下游靶蛋白乙酰辅酶 A 羧化酶的磷酸化,还可诱导凋亡和自噬。 | |||
T1511 |
Daunorubicin hydrochloride
Daunomycin HCl,盐酸佐柔比星,盐酸柔红霉素,RP-13057 Hydrochloride,Rubidomycin hydrochloride,Daunorubicin HCl,Daunomycin |
Apoptosis; DNA/RNA Synthesis; Topoisomerase; Antibacterial; Antibiotic; Autophagy | Apoptosis; Autophagy; Cell Cycle/Checkpoint; DNA Damage/DNA Repair; Microbiology/Virology |
Daunorubicin hydrochloride (Rubidomycin hydrochloride) 是一种蒽环类氨基糖苷类抗肿瘤药物,可抑制 DNA 复制和修复以及 RNA 和蛋白质合成。 | |||
T5749 |
10-Deacetyl-7-xylosyl paclitaxel
10-Deacetyl-7-xylosyltaxol,10-Deacetyltaxol 7-Xyloside,7-Xylosyl-10-deacetyltaxol,7-木糖甙-10-脱乙酰基紫杉醇,10-Deacetylpaclitaxel 7-Xyloside |
Others; Microtubule Associated | Cytoskeletal Signaling; Others |
10-Deacetyl-7-xylosyl paclitaxel (7-Xylosyl-10-deacetyltaxol) 是一种紫杉醇衍生物,具有改进的药理特性和更高的水溶性,用于治疗癌症。 | |||
T1456 |
Doxorubicin
Hydroxydaunorubicin,阿霉素,Adriamycin |
Topoisomerase; AMPK | Chromatin/Epigenetic; DNA Damage/DNA Repair; PI3K/Akt/mTOR signaling |
Doxorubicin (Adriamycin) 是一种有细胞毒性的蒽环类抗生素,具有肿瘤化疗作用。它抑制DNA 拓扑异构酶 I 和拓扑异构酶 II,IC50分别为0.8 μM 和2.67 μM,从而抑制 DNA 复制。它下调AMPK 的基础磷酸化以及下游 acetyl-CoA 羧化酶。它诱导凋亡和自噬 。 |